Get access to our best features
Get access to our best features
Published 25 days ago

Synchron, a rival to Musk’s Neuralink, readies large-scale brain implant trial

  • Synchron CEO Tom Oxley announced the launch of a BCI registry for users and physicians.
  • The registry aims to facilitate engagement and connection for potential users in preparation for clinical trials.
  • The CEO expressed excitement for the growth of a grassroots BCI movement.
Insights by Ground AI
Does this summary seem wrong?

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 67% of the sources are Center
66% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)